News
RedHill Gains Positive Momentum with FDA Feedback
July 21, 2025 • News
Companies mentioned:
RedHill Biopharma shares are trading higher after receiving positive FDA feedback on the pathway to approval for their groundbreaking RHB-204 program targeting Crohn's disease, signaling potential commercial opportunities in the expanding market.